Stephen J. Hill, Chief Operating Officer at Lyell Immunopharma, Inc. (LYEL), sold 185 shares at $10.53 ($2K) on 2025-08-11, disclosed to the SEC on 2025-08-13.
Open-market sale of $2k LYEL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.53 | 91 | $958 | 49.6% |
| 2 | $10.34 | 94 | $972 | 50.4% |
| Total | $10.43 avg | 185 | $2K | 100% |
| Filing → |
| LYEL | SELL | 2026-06-15 | $2K | — | Filing → |
| LYEL | SELL | 2026-02-12 | $29K | — | Filing → |
| LYEL | SELL | 2026-02-11 | $3K | — | Filing → |